is tirzepatide a glp-1 receptor agonist Semaglutide vs. Tirzepatide: Which Wins? GLP-1 Receptor Agonists - Mechanisms
Description
Best results are achieved alongside a healthy diet and consistent exercise
The key takeaway
Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Their potential for disease modification and symptom relief, particularly in specific phenotypes, supports their further exploration as part of a personalized treatment approach.
